Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models

Therapeutic options against SARS-CoV-2 are underutilized. Two oral drugs, molnupiravir and paxlovid (nirmatrelvir/ritonavir), have received emergency use authorization. Initial trials suggested greater efficacy of paxlovid, but recent studies indicated comparable potency in older adults. Here, we co...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Robert M., Lieber, Carolin M., Wolf, Josef D., Karimi, Amirhossein, Lieberman, Nicole A. P., Sticher, Zachary M., Roychoudhury, Pavitra, Andrews, Meghan K., Krueger, Rebecca E., Natchus, Michael G., Painter, George R., Kolykhalov, Alexander A., Greninger, Alexander L., Plemper, Richard K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406822/
https://www.ncbi.nlm.nih.gov/pubmed/37550333
http://dx.doi.org/10.1038/s41467-023-40556-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406822/
https://www.ncbi.nlm.nih.gov/pubmed/37550333
http://dx.doi.org/10.1038/s41467-023-40556-8

Ejemplares similares